Patients with Parkinson's share daily strategies and patient accounts that transform how others approach living with this progressive neurological condition.
Read more →
Parkinson's disease can cause a dangerous blood pressure paradox: high pressure while lying down and dangerously low pressure when standing.
Read more →
Disease-modifying therapies now drive Parkinson's research, targeting neurodegeneration itself rather than just managing movement symptoms.
Read more →
Tremors and dyskinesia are distinct involuntary movements in advanced Parkinson's, arising from different causes and requiring separate management approaches.
Read more →
After retirement and a Parkinson's diagnosis, one patient rediscovered purpose and identity through the act of making art.
Read more →
Amneal Pharmaceuticals faces documented legal challenges in 2026, but no verified lawsuit exists about challenging generic Parkinson's medication copies.
Read more →
Early Parkinson's often hides in plain sight—subtle tremor, stiffness, and slowness that seem like normal aging until you recognize the pattern.
Read more →
A major stem cell therapy trial for Parkinson's disease has finished enrolling participants, marking a critical milestone in experimental treatment research.
Read more →
A father with Parkinson's climbed Africa's tallest peak with his daughter, defying assumptions about what the disease allows.
Read more →
Depression medications often lose their power as Parkinson's and Alzheimer's disease progress, a challenge rooted in how neurodegeneration alters brain chemistry itself.
Read more →
Healthcare providers trained in Parkinson's mental health recognize depression, anxiety, and apathy as treatable dimensions of disease care.
Read more →
A $6 million grant to Banner Sun Health accelerates the development of blood tests that could identify Parkinson's disease earlier than current clinical methods.
Read more →
Phase 1b/2a trial enrollment completion signals progress in evaluating RNDP-001, but approval remains years away.
Read more →
Scientists are investigating whether restoring healthy gut bacteria could slow or prevent Parkinson's disease.
Read more →
FDA approval of new delivery methods and dozens of emerging Parkinson's therapies in clinical trials are reshaping treatment options in 2026.
Read more →
A major 2026 Mexican study identified 32 genetic variants linked to Parkinson's disease, shifting understanding of genetic risk in understudied populations.
Read more →
Early Parkinson's diagnosis unlocks years of independence that cannot be reclaimed once lost to unrecognized disease progression.
Read more →
This disclosure joins a growing number of public figures and artists who have chosen to speak openly about their neurological diagnoses, bringing...
Read more →
Early tremor and stiffness often develop quietly, making them easy to overlook until movement changes accumulate enough to disrupt daily routines.
Read more →
Drug approval delays in India leave Parkinson's patients waiting years for treatments available globally.
Read more →